For what it's worth it was a phone conversation.
Other items discussed.
HK IPO will be address with the next quarterly update. IMO it will be either delayed until NMPA and MOU conversion. Or cancelled due to GEM funding facility in place.
Yacov to do more publicity in Australia.
The stock is on the radar of some small and micro cap managers. But these guys won't be doing anything until they too are convinced of the companies strategy and meet Yacov.
So this conversation is just that, just talk. Like any previous GMV announcement it's all words. Yacov needs to pull his f*#£ing finger out and make some changes. Listen to the market and his shareholders and start doing something positive on the investor relations front.
He may have a great track record in medical devices and regulatory bodies. Stick to your knitting. Let's hope with the appointment of 6 Degrees Investor Relations he has made changes for the better.
A lot of anticipation with the next quarterly update.
- Forums
- ASX - By Stock
- GMV
- GMV The Future
GMV The Future, page-828
-
- There are more pages in this discussion • 2,186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online